NEW YORK, July 10, 2012 /PRNewswire/ -- La Jolla Pharmaceutical Company (OTCQB: LJPC) today announced that their Chief Executive Officer, George F. Tidmarsh, MD, PhD, will present at RetailInvestorConferences.com.
July 12, 2012
6:00 PM EDT
www.retailinvestorconferences.com > red "register / watch event now" button
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register to save time and receive event updates.
About La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company is a biopharmaceutical company dedicated to the development of treatments that significantly improve outcomes in patients with life-threatening diseases. Our team is pioneering the science of galectins to develop innovative new therapies to treat human diseases such as cancer and chronic organ failure.
Since 2010, RetailInvestorConferences.com, created by BetterInvesting (NAIC) PR Newswire and MUNCmedia, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.
SOURCE La Jolla Pharmaceuticals